Items tagged with Diagnostics
TB LAM testing briefs (post with simple image)
Two important tools for activists to use with donors and national TB programs in advocating for increased scale-up of the inexpensive, urine TB LAM test - an essential diagnostic test for TB in people living with HIV.
MSF technical brief: A rapid TB test for people living with HIV (post with simple image)
TB LAM can help close the deadly TB testing gap.
Time to lower the price of Xpert cartridges to $5 (post with simple image)
Advocates request Cepheid immediately reduce the price of Xpert tests to $5, inclusive of service and maintenance; Cepheid claims costs for each Xpert cartridge "substantially exceed" the requested price target of $5, but does not provide evidence to support this claim.
Protestors demand Cepheid halve the price of GeneXpert TB tests to US$5 (post with simple image)
The high cost of GeneXpert tests for TB leaves open a critical gap in the diagnosis of TB and fails to consider volume of sales and public investments in the development of GeneXpert.
TAG’s 2019 Pipeline Report: Three TB sections released (post with simple image)
The sections provide an overview of TB diagnostics, vaccines and treatment.
WHO updates policy for the use of TB LAM test (post with simple image)
The World Health Organization now recommends more broader use of urinary LAM assays for diagnosis of TB in people living with HIV.
An Activist's Guide to the TB LAM Test (post with simple image)
Treatment Action Group releases an updated version of its Activist’s Guide to the LAM Test with a complementary resource that tracks the status of LAM uptake in the 30 high TB/HIV burden countries.
TAG statement on the high price of Cepheid’s Xpert test for COVID-19 (post with simple image)
Cepheid is profiteering during a pandemic, with dangerous consequences for countries with vulnerable populations and health systems.
Civil society call for equitable and affordable access to COVID-19 and related diagnostics (post with simple image)
Advocates call for a higher level of global coordination, transparency, and accountability to ensure sustainable and equitable access to testing.
WHO urges countries to expand access to rapid molecular tests for the detection of TB and drug-resistant TB (post with simple image)
WHO releases updated guidelines for TB diagnosis, recommending rapid molecular tests as initial tests for TB detection.
Page 66 of 70 · Total posts: 0
←First 65 66 67 Last→